StockData

Delcath Systems vs Pulmonx

DCTH and LUNG side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DCTH and LUNG compare

Delcath Systems is the larger company, worth 5.7 times as much as Pulmonx ($672M against $117M).

Delcath Systems grew revenue faster over the last twelve months (35.8% versus −3.4% for Pulmonx).

Delcath Systems keeps more of each dollar of sales as profit, with a net margin of 0.56% compared with −55.0% at Pulmonx.

Delcath Systems scores higher on the StockData Score (13 against 7 for Pulmonx), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDCTHLUNG
Size and price
Market cap$672M$117M
Share price$19.37$2.73
Change, 1 year117%83.6%
Change, 5 years98.9%−91.9%
Beta (5Y)1.982.51
Employees156296
StockData Score
Total score13 (better)7
Valuation score03 (better)
Growth score4 (better)2
Performance score3 (better)1
Health score6 (better)1
Dividend score00
Valuation
P/E1937×–
P/S7.0×1.3× (better)
P/B5.5×3.0× (better)
P/FCF38.4×–
FCF yield2.6% (better)−26.1%
Fair value–$4.87
Margin of safety–43.8%
Growth
Revenue growth (TTM)35.8% (better)−3.4%
Revenue growth, 5Y average–22.6%
Net income growth (TTM)−76.2%–
EPS growth (TTM)−80.0%–
Profitability
Gross margin87.1% (better)77.1%
Operating margin−1.9% (better)−53.0%
Net margin0.56% (better)−55.0%
FCF margin18.3% (better)−35.1%
Return on equity0.47% (better)−88.9%
Return on invested capital−3.7% (better)−142%
Financial health
Debt / equity0.000.96 (better)
Interest coverage–−12.3×
Current ratio9.83 (better)4.32
Altman Z-score21.70 (better)−5.58
Piotroski F-score7 (better)3
Dividends and buybacks
Buyback yield−0.09%–
Shareholder yield−0.09%0.00% (better)
Ownership
Held by institutions50.2%61.0%
Held by insiders37.4%16.6%
Insider net buying, 12 months−$338K (better)−$548K
Short interest, % of float8.2%2.2%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.